Condensed consolidated and combined statements of cash flows (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Operating activities
Net loss	$ (5,424,759)	$ (811,502)	$ (9,652,437)	$ (1,821,769)
Non-cash items and reclassifications:
Amortization	71,938	15,592	90,176	30,377
Financing costs			319,635
Fees and penalty on bank loan repayment			100,000
Gain on sale of equipment		(68,502)		(97,898)
Amortization and extinguishment of remaining discount on preferred stock upon conversion of preferred stock		119,450	1,884,233	144,888
Change in fair value of derivative liabilities	(14,501)	(947,886)	(928,430)	(947,886)
Stock-based compensation	214,822	73,483	352,476	128,157
Stock-based purchase of patent rights	186,356		186,356
Foreign exchange loss and other	(972)		105,529
Changes in operating assets and liabilities:
Accounts and other amounts receivable	33,151	(12,846)	(5,429)	(13,016)
Prepayments and deposits	185,335	(8,424)	(268,370)	2,056
Accounts payable and accrued liabilities	1,941,810	199,069	1,207,273	236,904
Cash used in operating activities	(2,806,820)	(1,441,566)	(6,608,988)	(2,338,187)
Investing activities
Purchase of investments	(34,474,541)		(34,474,541)
Proceeds from maturity of investments	2,714,100		2,714,100
Purchase of property and equipment	(64,611)	(2,537)	(69,074)	(7,233)
Sale of property and equipment		104,353		155,163
Cash (used in) provided by investing activities	(31,825,052)	101,816	(31,829,515)	147,930
Financing activities
Repayment of bank loan, fees and penalty			(2,600,000)
Preferred stock (redemption) issued			(491)	17,999,961
Share issue costs		(87,870)		(220,611)
Initial public offering of common shares			53,130,000
Initial public offering costs	(390,345)		(5,201,288)
Cash (used in) provided by financing activities	(390,345)	(87,870)	45,328,221	17,779,350
Increase (decrease) in cash and cash equivalents during the period	(35,022,217)	(1,427,620)	6,889,718	15,589,093
Cash and cash equivalents, beginning of period	52,918,327	19,017,252	11,006,392	2,000,539
Cash and cash equivalents, end of period	17,896,110	17,589,632	17,896,110	17,589,632
Supplemental disclosure of cash flow information:
Interest paid			31,719
Interest received	46,837		49,672
Non-cash financing activities:
Accrued offering costs	$ 50,000		$ 50,000